ResMed Inc. (RMD) has exhibited a bearish trend over the recent months, with the stock price declining approximately 13% over the past three months and 8% year-to-date. The price has retreated from higher levels near 294, now hovering around 222 in pre-market trading, close to the 52-week low of 216.68. This downtrend is evident as RMD remains firmly below its key moving averages, reflecting sustained selling pressure. Over the last 30 days, price action has shown consolidation near recent lows, with limited upside momentum amid broader market caution in the healthcare sector.
Traders are closely monitoring a support cluster between 217 and 219, reinforced by recent lows and a noted support zone from 219.50 to 219.84. Pivot point analysis highlights classic S1 at 208.51 and Fibonacci S1 at 218.38, providing deeper support levels. On the upside, immediate resistance lies near 223-225, aligning with short-term EMAs and pivot R1 around 224-250. The pivot point itself stands at 234.36, a level that could cap any recovery attempts if breached downward.
All major simple and exponential moving averages signal sell, underscoring the bearish structure. The 10-day EMA is at 223.32, 20-day EMA at 225.76, 50-day SMA at 236.43, 100-day SMA at 244.64, and 200-day SMA at 256.56. RMD's current position below these levels confirms the downtrend, with the stock trading roughly 10-15% below the 50-day SMA. The Hull Moving Average (9) at 218.86 offers a buy signal, potentially acting as dynamic support.
Oscillators present a neutral picture overall. The RSI (14) reading of 40.42 remains in neutral territory, avoiding oversold extremes but indicating waning bullish momentum. Stochastic %K at 20.74 and Williams %R at -70.70 point toward oversold conditions, which could precede a bounce. Meanwhile, MACD (12,26) at -3.64 generates a buy signal, alongside buys from Stochastic RSI Fast (15.61) and Momentum (10), suggesting possible divergence and short-term relief in the downtrend.
Trading volume has averaged 1.1 million shares daily, with recent sessions around 1 million, showing no significant spikes or unusual activity. This steady volume supports the consolidation phase without strong conviction for either direction, typical in downtrends testing support.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to analyze vast market data, technical indicators, and price patterns, generating actionable buy or sell signals for stocks like RMD. These signals draw from trend recognition, historical pattern matching, and momentum factors to pinpoint potential entry and exit points. Traders rely on them to confirm ongoing trends, spot reversals, and enhance decision-making processes. By integrating machine learning with proven technical frameworks, the AI provides objective insights amid market noise. Explore the AI Daily Buy/Sell Signals to see how they apply to RMD.
Traders will watch for a hold above the 217-219 support zone to avoid further downside toward pivot S1 at 208. A break below could accelerate the downtrend. Conversely, a push above 223-225 and the 10-day EMA may signal short-term bullish momentum, targeting the pivot at 234. Monitor MACD for sustained buy confirmation, RSI for oversold bounces, and volume for conviction on any breakout. The alignment of moving averages remains a hurdle for bulls.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, RMD has been loosely correlated with COO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To RMD | 1D Price Change % | ||
|---|---|---|---|---|
| RMD | 100% | -1.79% | ||
| COO - RMD | 48% Loosely correlated | N/A | ||
| SOLV - RMD | 46% Loosely correlated | -1.39% | ||
| BAX - RMD | 44% Loosely correlated | -3.18% | ||
| NVST - RMD | 40% Loosely correlated | -2.48% | ||
| RVTY - RMD | 40% Loosely correlated | +0.04% | ||
More | ||||
| Ticker / NAME | Correlation To RMD | 1D Price Change % |
|---|---|---|
| RMD | 100% | -1.79% |
| Pharmaceuticals category (159 stocks) | 26% Poorly correlated | +6.22% |
| Pharmaceuticals: Other category (55 stocks) | 22% Poorly correlated | +0.78% |